Interventional Cardiology Market to Reach $28.91 Billion by 2032 Driven by Rising Cardiac Diseases, Minimally Invasive Procedures, and Technological Advancements

Market Overview

The Interventional Cardiology Market, valued at USD 14.56 billion in 2022, is anticipated to witness significant growth, reaching USD 28.91 billion by 2032, with a projected compound annual growth rate (CAGR) of 7.1% during the forecast period (2023 - 2032).

Interventional cardiology focuses on treating heart diseases using catheter-based procedures. Across global regions, there has been a notable increase in the incidence of cardiac ailments, largely attributed to lifestyle changes leading to an upsurge in lifestyle-related diseases. Annually, cardiovascular diseases account for 3.9 million deaths in Europe and over 1.8 million deaths within the European Union (EU).

Get Free Sample PDF Brochure: https://www.marketresearchfuture.com/sample_request/8735

Market Trends

Surge in Minimally Invasive Procedures: There is a growing preference for minimally invasive procedures due to their associated benefits such as reduced post-operative pain and quicker recovery.

Favorable Reimbursement Landscape: Developed countries, like Germany, offer favorable reimbursement scenarios, such as reimbursing angioplasty with stenting using bare-metal stents solely through the diagnosis-related group (DRG) system.

Government Support: Government organizations, like India's National Pharmaceuticals Pricing Authority (NPPA), have taken measures to reduce prices, with an 85% decrease in stent prices in 2017, promoting accessibility to interventions.

Increased Incidence of Cardiac Diseases: Both developing and developed countries are witnessing a rise in the incidence rates of cardiac diseases, driving the demand for interventional cardiology procedures.

Collaborations and Partnerships: Key players are forming partnerships and collaborations with local entities to expand their reach and enhance their product portfolios.

Technological Advancements: The interventional cardiology industry is experiencing continuous technological advancements and innovation, enhancing treatment efficacy and patient outcomes.

Research and Development Investment: There is a significant investment in research and development within the field, driving continuous improvements and advancements.

Growing Awareness: Medical professionals and key players are actively raising awareness among patients about the benefits of interventional cardiology procedures compared to traditional open surgeries, contributing to increased acceptance and adoption.

Buy Now Premium Research Report: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=8735

Interventional Cardiology Market Key Players

ABIOMED (US)
Abbott (US)
ACIST Medical Systems, Inc. (US)
Braun Melsungen AG (Germany)
BD (US)
Biosense Webster, Inc (US)
Biotronik SE & Co. KG (Germany)
Boston Scientific Corporation (US)
Cardinal Health (US)
Cook Medical (US)
Edwards Lifesciences Corporation (US)
GE Healthcare (US)
Koninklijke Philips N.V. (Netherlands)
Life Vascular Devices Biotech S.L. (Spain)
Medtronic (Ireland)
Merit Medical Systems, Inc (US)
Terumo Corporation (Japan)
Gore & Associates, Inc. (US)

Regional Analysis:

The Interventional Cardiology Market is segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. In the base year 2018, the Americas dominated the market, driven by high incidence rates of cardiac disorders and strategic initiatives by major players, particularly in the US. Within the Americas, North America and Latin America are distinguished, with the former further divided into the US and Canada.

Europe's interventional cardiology market is segmented into Western Europe and Eastern Europe, with Western Europe including major countries like Germany, France, the UK, Italy, Spain, and others. The European market is expected to hold a significant share due to the rising number of cardiac disorder cases, exemplified by the 2016 statistic of 66,076 deaths due to coronary heart diseases in the UK alone.

Browse In-depth Market Research Report (113 Pages) on Interventional Cardiology: https://www.marketresearchfuture.com/reports/interventional-cardiology-market-8735

In the Asia-Pacific region, comprising countries such as Japan, China, India, South Korea, Australia, and others, the interventional cardiology market is anticipated to witness the highest growth during the forecast period. This growth is propelled by increasing adoption rates of newer treatment options and rising mortality rates from cardiac diseases, such as ischemic heart disease, which was the second-highest cause of death in Japan in 2017.

The Middle East & Africa segment is divided into the Middle East and Africa regions.

Segmentation:

The Global Interventional Cardiology Market is segmented based on Type and End User.

Type segmentation includes stents, percutaneous transluminal coronary angioplasty (PTCA) catheters, plaque modification devices, coronary guidewires, and accessories. Within stents, sub-categories include drug-eluting stents, bare-metal stents, and bioresorbable vascular scaffolds. The stents segment dominated, driven by key player launches and is expected to continue growing rapidly due to increased prevalence of coronary artery disease and ongoing innovations.

End-user segmentation includes hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and others. Hospitals accounted for the majority share due to increased patient admissions for coronary diseases. The cardiac catheterization laboratory segment is projected to grow fastest, reflecting medical professionals' preference for cath labs.

More Trending Reports:

Dental Practice Management Software Market - https://www.marketresearchfuture.com/reports/dental-practice-management-software-market-6507

ePharmacy Market - https://www.marketresearchfuture.com/reports/epharmacy-market-6615

Clinical Reference Laboratory Market - https://www.marketresearchfuture.com/reports/clinical-reference-laboratories-market-1190

About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis regarding diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com

This release was published on openPR.